Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Bryn Mawr, Pennsylvania 19010


Purpose:

Asthma in the elderly is poorly understood, as most studies have not included this patient group. In a previous study of adults with asthma, choline supplementation had a positive effect on asthma symptoms and allowed to decrease asthma pharmacologic treatment. The present study is a randomized, double-blind, placebo-controlled, cross-over study of choline supplementation. The investigators will study the effect of choline 650 mg taken orally twice daily x 6 weeks versus placebo on asthma symptom scores (Asthma Control Test) and spirometric values (FEV1, FEV1/FVC, FEF25-75%). The investigators will also look at the effect of choline supplementation on peripheral blood eosinophils, serum immunoglobulin E (IgE) and homocysteine levels.


Criteria:

Inclusion Criteria: - Asthma Exclusion Criteria: - No history of smoking more than 10 pack/years, - no gastrointestinal cancers, - no liver or kidney disease, - no bipolar disorder.


NCT ID:

NCT02371993


Primary Contact:

Principal Investigator
Michele Columbo, M.D.
Rohr and Columbo Asthma, Allergy and Immunology Specialists


Backup Contact:

N/A


Location Contact:

Bryn Mawr, Pennsylvania 19010
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.